Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. It undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. The company is headquartered in Calgary, Canada.
Stock data | 2023 | Change |
---|---|---|
Price | $0.01355 | N/A |
Market Cap | $2.59M | N/A |
Shares Outstanding | 191.30M | 3.05% |
Employees | 0 | N/A |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | -1.35 | N/A |
P/S Ratio | 3.43 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $756.54K | N/A |
Earnings | -$1.76M | N/A |
EPS | -0.01 | N/A |
Earnings Yield | -0.738 | N/A |
Operating Margin | -1.99 | N/A |
Net income margin | -2.32 | N/A |